Teva Pharmaceutical Industries Ltd. — Board/Management Information 2017

Feb 6, 2017

_________ false

��� ������ ��������� ��"�	2 380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no: 520013954	10817
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	07/02/2017
	www.isa.gov.il			www.tase.co.il				Reference:	2017-02-011578	Time of broadcast: 00:05 00:04:57

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on ��� ���� �� ����' ���� ������� ����"� ����� �� �����, ������ �� ��� �������
TEVA_Management_Change_Press_Release_-_ENG-HEB_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NYSE	Date of revision of form structure: 30/01/2017
Address: P.O.B 3190 , Petach Tikva 49131   , Tel: 03-9267267 , 03-9267652 Fax: 03-9267519
E-mail address: tomer.amitai@teva.co.il
Previous names of reporting entity:
Name of the Signatory: Beck Codner Iris Position of Signatory in the reporting corporation: Vice President, Global Corporate Communication Name of Employer Company:
Address: Basel 5 , Petach Tikva 49131 Telephone: 03-9267208 Facsimile: 03-9267851 E-mail: iris.beckcodner@teva.co.il 1